https://www.avient.com/investor-center/news/avient-hold-second-quarter-2024-conference-call
View original content to download multimedia:https://www.prnewswire.com/news-releases/avient-to-hold-second-quarter-2024-conference-call-302192554.html
https://www.avient.com/investor-center/news/avient-hold-third-quarter-2024-conference-call
View original content to download multimedia:https://www.prnewswire.com/news-releases/avient-to-hold-third-quarter-2024-conference-call-302267313.html
https://www.avient.com/investor-center/news/avient-hold-second-quarter-2021-conference-call
View original content to download multimedia:https://www.prnewswire.com/news-releases/avient-to-hold-second-quarter-2021-conference-call-301323596.html
https://www.avient.com/investor-center/news/avient-hold-third-quarter-2022-conference-call
View original content to download multimedia:https://www.prnewswire.com/news-releases/avient-to-hold-third-quarter-2022-conference-call-301646567.html
https://www.avient.com/news/polyone-inspiring-electric-vehicle-designs-lineup-trendsetting-polymer-colors
PolyOne is supporting this trend with novel colors that add a spark of originality.
https://www.avient.com/investor-center/news/polyone-begin-thermoplastic-elastomer-production-india
View original content:http://www.prnewswire.com/news-releases/polyone-to-begin-thermoplastic-elastomer-production-in-india-300595390.html
https://www.avient.com/investor-center/news/avient-announces-fourteenth-consecutive-annual-dividend-increase
View original content to download multimedia:https://www.prnewswire.com/news-releases/avient-announces-fourteenth-consecutive-annual-dividend-increase-302272152.html
https://www.avient.com/investor-center/news/avient-hold-fourth-quarter-2024-conference-call
View original content to download multimedia:https://www.prnewswire.com/news-releases/avient-to-hold-fourth-quarter-2024-conference-call-302350532.html
https://www.avient.com/sites/default/files/2022-12/Mevopur Healthcare Colorants and Formulations_Functional Additives for IVD Devices Bulletin.pdf
KEY CHARACTERISTICS • Manufactured at four ISO 13485 certified manufacturing sites, providing global consistency and increased security of supply • Documented change control beyond CAS number, reducing risk of change • Non-phthalate and formulated without animal-derived substances • Available as concentrates or ready-to-use formulations in a wide range of polymers • Functionality and color can be combined in one product for convenience REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 and USP biological evaluation - European Pharmacopeia 3.1.3/3.1.5 (polyolefin) - USP (polyethylene) - ICH Q3D elemental impurities • Registered Drug Master File (Type III) and/or Device Master File • Documentation support for approval or transition to comply with (new) regulations such as IVDR APPLICATION BULLETIN Healthcare use limitations apply—see below.
https://www.avient.com/investor-center/news/avient-hold-first-quarter-2025-conference-call
View original content to download multimedia:https://www.prnewswire.com/news-releases/avient-to-hold-first-quarter-2025-conference-call-302419843.html